Tweets

Je hebt @stephensempie geblokkeerd

Weet je zeker dat je deze Tweets wilt bekijken? @stephensempie wordt niet gedeblokkeerd door Tweets te bekijken.

  1. Vastgemaakte Tweet
    6 jun.

    Aim for a big June trading update on H1 further contracts from world class bod guaranteed improved results looking for a big bounce & oculus rift launch NDA submitted to FDA for approval ippc? Strategic update May very well be a cracker

    Ongedaan maken
  2. 28 jun.

    Never mind all this talk of finishing 1st or 2nd in the group. We NEED to finish second, otherwise the last 16 match @ 7pm clashes with my wedding anniversary 🙄🙄🙄🤪🤪🤪🤔🤔🤔🤔

    Ongedaan maken
  3. 28 jun.

    - from all the shares I own, I believe that this is the most imminent rerate. Think we should be looking at 50% uplift in the next 4 weeks. So much news on multiple fronts, but as always dyor

    Ongedaan maken
  4. heeft geretweet
    27 jun.

    We take steps to achieve a better world through technology! Systems is proud to support in the vision of a cleaner future for ! The accord provides a roadmap to get us to that bright future, faster! Learn more

    Ongedaan maken
  5. 27 jun.

    Brazil starting to play with a bit of swagger now. They've finally arrived at the world cup

    Ongedaan maken
  6. heeft geretweet
    26 jun.

    GOLD CROSS COMING 👍🚀🚀🚀🚀

    Deze collectie tonen
    Ongedaan maken
  7. 26 jun.

    looks great imo, charts driven down for the last year, despite already having good revenues. Couple with phase 3 results results in Q3. As always, binary with , but success or failure the company has the fundamentals to withstand regardless of results. Rvr excellent

    Ongedaan maken
  8. heeft geretweet
    26 jun.

    warrants no longer a drag and move on to the historically busier Q3 and Q4 ..with Q1 doing $1.5mln i would expect $1.75/2 for Q2 And more for H2 ...for £6.6mln cap ..pretty impressive versus peers and versus 2017 numbers

    Deze collectie tonen
    Ongedaan maken
  9. 25 jun.

    Taken a position in , people often talk about companies bring undervalued, but prices are truly a gift. Simple case if waiting it out and collecting your profit. Think that a bag is on from here. Ps I can also confirm the early trades today distorted market. All buys today

    Ongedaan maken
  10. heeft geretweet
    22 jun.

    Interesting - rose considerably 2 days before the bigger rise when news officially broke. There was also a smaller gap, which closed yesterday with the 1 million sold at 1.6p. Given fundamentals have changed for the better this year the set-up is better than it looks IMO

    Ongedaan maken
  11. 18 jun.

    Another concise interview from GL at , really getting to the closing stages of cycle. Offering unreal value, being able to buy at pre result levels, even though all the endpoints have been met. 2months for acceptance, then 6 months for approval

    Ongedaan maken
  12. 18 jun.
    Ongedaan maken
  13. heeft geretweet
    18 jun.

    Braveheart’s profits nearly double as portfolio value jumps via

    Ongedaan maken
  14. heeft geretweet
    18 jun.

    very strong 2017 performance and outlook for the 3 key portfolio businesses extremely positive.

    Ongedaan maken
  15. 15 jun.

    now that's how you end an afternoons trading. Big, actually HUGE week next week. Which may very well make today look incredibly cheap

    Ongedaan maken
  16. 14 jun.

    have finally submitted to . Another hurdle complete. With priority review & hit the endpoints for efficacy & safety. This share is truly on countdown.

    Ongedaan maken
  17. heeft geretweet
    12 jun.

    What we know should be announced, and what I'm expecting, from results in a weeks time

    Ongedaan maken
  18. 12 jun.

    it really is apparent that p3 trials are tough in , so if you find a small cap like - it really is somewhat special. Data peer review, endpoints and safety profile hits endpoints. not as sexy as others, but urgently required

    Ongedaan maken
  19. 11 jun.

    Increased holdings in today, science works and I'm confident will be approved. NDA should be this month, GL generally good @ delivering on targets. People need to understand this isn't meant to replace vanc, but target renal patients that vanc isn't good for

    Ongedaan maken
  20. 11 jun.

    Oh the enigma that is successful p3 trials, NDA imminent. But you need the deductive sleuthing of Jessica Fletcher, poirot & Sherlock Holmes to work out what BoA, sandgrove & now HSBC are doing. II interest is better than none though

    Ongedaan maken
  21. heeft geretweet
    11 jun.

    And another nice buy looking for a break above 50dma shortly

    Deze collectie tonen
    Ongedaan maken

Het laden lijkt wat langer te duren.

Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.

    Je bent misschien ook geïnteresseerd in

    ·